A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema
Clinical trial NCT05224102 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05224102
- Sponsor
- Genentech, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-28
- Primary completion
- 2027-01-26
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.